Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Eradication

• Váldodahkkit: Hyun Soo Kim (Dahkki), Hyuk Yoon (Dahkki), Dong Woo Shin (Dahkki), Dong Jun Oh (Dahkki), Mingu Kwon (Dahkki), Yoon Jin Choi (Dahkki), Cheol Min Shin (Dahkki), Young Soo Park (Dahkki), Nayoung Kim (Dahkki), Dong Ho Lee (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Yong Chan Lee, 2020-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background/Aims The treatment options for Helicobacter pylori (H. pylori) infection are in a state of flux: traditional triple therapies have started to fail, and new treatments are unable to achieve optimal eradication rates. Rifaximin and rifabutin are new antibiotics. The aim of this study was to...